| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | COMMUNITY HEALTH SYS INC NEW | 304,472 | 3,669,000 | 0.15% | ||
| 52 | NEVRO CORP COM | 49,800 | 3,673,000 | 0.15% | ||
| 53 | ARIAD PHARMACEUTICALS ORD (NMS) | 502,000 | 3,710,000 | 0.15% | ||
| 54 | ACCELERATE DIAGNOSTICS INC | 264,625 | 3,808,000 | 0.16% | ||
| 55 | VALEANT PHARMACEUTICALS INTL | 192,000 | 3,867,000 | 0.16% | ||
| 56 | DEPOMED INC | 200,000 | 3,924,000 | 0.16% | ||
| 57 | EPIZYME INC COM | 400,000 | 4,096,000 | 0.17% | ||
| 58 | ALLERGAN PLC | 5,000 | 4,168,000 | 0.17% | ||
| 59 | PRA HEALTH SCIENCES INC | 102,000 | 4,260,000 | 0.17% | ||
| 60 | SAGENT PHARMACEUTICALS INC | 286,650 | 4,294,000 | 0.18% | ||
| 61 | ULTRAGENYX PHARMACEUTICAL INC COM | 88,400 | 4,324,000 | 0.18% | ||
| 62 | SAGE THERAPEUTICS INC | 146,800 | 4,423,000 | 0.18% | ||
| 63 | ENDO INTL PLC | 286,348 | 4,464,000 | 0.18% | ||
| 64 | BIOMARIN PHARMACEUTICAL INC | 57,700 | 4,489,000 | 0.18% | Call | |
| 65 | MYLAN N V | 104,600 | 4,523,000 | 0.18% | Call | |
| 66 | TENET HEALTHCARE CORP | 164,500 | 4,547,000 | 0.19% | ||
| 67 | GILEAD SCIENCES INC | 57,400 | 4,788,000 | 0.20% | Call | |
| 68 | ALKERMES PLC | 111,900 | 4,836,000 | 0.20% | Call | |
| 69 | ABBOTT LABS | 123,800 | 4,866,000 | 0.20% | Call | |
| 70 | NEUROCRINE BIOSCIE COM USD0.001 | 110,400 | 5,018,000 | 0.20% | Call | |
| 71 | DYNAVAX TECHNOLOGIES CORP | 345,050 | 5,031,000 | 0.21% | ||
| 72 | ICON PLC | 72,000 | 5,041,000 | 0.21% | ||
| 73 | EGALET CORP | 7,000,000 | 5,281,000 | 0.22% | PRN | |
| 74 | LTC PPTYS INC COM | 106,212 | 5,494,000 | 0.22% | ||
| 75 | RETROPHIN INC | 329,949 | 5,876,000 | 0.24% | ||
| 76 | FOAMIX PHARMACEUTICALS LTD | 966,065 | 6,135,000 | 0.25% | ||
| 77 | Pieris Pharmaceuticals | 3,848,191 | 6,196,000 | 0.25% | ||
| 78 | Bristol-Myers Squibb Co. | 87,300 | 6,421,000 | 0.26% | Put | |
| 79 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 624,288 | 6,705,000 | 0.27% | ||
| 80 | ENDOLOGIX INC | 551,000 | 6,865,000 | 0.28% | ||
| 81 | AKORN INCORPORATED | 245,235 | 6,986,000 | 0.29% | ||
| 82 | JUNO THERAPEUTICS INC COM | 182,000 | 6,996,000 | 0.29% | ||
| 83 | Wright Medical Group NV | 402,950 | 6,999,000 | 0.29% | ||
| 84 | INTRA-CELLULAR THERAPIES INC | 187,800 | 7,290,000 | 0.30% | ||
| 85 | AEGERION PHARMACEUTICALS INC | 13,000,000 | 7,410,000 | 0.30% | PRN | |
| 86 | SUPERNUS PHARMACEUTICALS INC | 2,000,000 | 7,688,000 | 0.31% | PRN | |
| 87 | CYNAPSUS THERAPEUTICS INC | 460,207 | 7,708,000 | 0.31% | ||
| 88 | CYTOMX THERAPEUTICS INC COM | 756,090 | 7,723,000 | 0.32% | ||
| 89 | PUMA BIOTECHNOLOGY | 260,200 | 7,751,000 | 0.32% | ||
| 90 | GALAPAGOS NV | 147,738 | 8,195,000 | 0.33% | ||
| 91 | CELLECTIS S A | 310,250 | 8,250,000 | 0.34% | ||
| 92 | CENTENE CORP DEL | 120,000 | 8,564,000 | 0.35% | ||
| 93 | CEPHEID | 10,000,000 | 8,669,000 | 0.35% | PRN | |
| 94 | HERON THERAPEUTICS INC COM | 492,303 | 8,886,000 | 0.36% | ||
| 95 | The Medicines Company | 279,600 | 9,403,000 | 0.38% | Call | |
| 96 | SABRA HEALTH CARE REIT INC | 456,190 | 9,413,000 | 0.38% | ||
| 97 | UNITED THERAPEUTICS CORP DEL | 93,100 | 9,861,000 | 0.40% | ||
| 98 | DEPHEID | 333,590 | 10,258,000 | 0.42% | ||
| 99 | PARATEK PHARMACEUTICALS INC | 762,581 | 10,608,000 | 0.43% | ||
| 100 | Natera, Inc. | 882,358 | 10,646,000 | 0.43% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-16-139243, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
